Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 21 Oct 2021 |
2 | Reply to Exam Report (MIS-R) | 12 Jan 2022 |
3 | Authorization Letter | 29 Jan 2024 |
4 | TM-M(EXTENSION OF TIME) | 30 Jan 2024 |
5 | Authorization Letter | 20 Feb 2024 |
6 | TM-M(EXTENSION OF TIME) | 21 Feb 2024 |
7 | Documents in support of Show cause Hearing (SCH) | 22 Aug 2024 |
8 | Journal Copy | 28 Sep 2024 |
1 | EXAMINATION REPORT | 12612247 | 08 Dec 2021 | |
2 | Hearing Notice (Show Cause) | 17005446 | 02 Jan 2024 | |
3 | Hearing Notice (Show Cause) | 17381796 | 12 Feb 2024 | |
4 | Hearing Notice (Show Cause) | 18035050 | 25 Apr 2024 | |
5 | Hearing Notice (Show Cause) | 18534645 | 19 Jul 2024 | |
6 | Tribunal Accepted Notice for : 5181281 | 18830197 | 6903012 | 10 Sep 2024 |
Trademark was applied on 21 October 2021 with IP India.
Proprietor of Niccef is AKUMS DRUGS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Niccef is Accepted & Advertised.
Application number alloted to the trademark is 5181281.
Trademark has been filed in the following category:
WORD